Asymmetric DBS for PD : A Multicenter, Prospective, Single Arm, Open Label Study
Trial
N/A
Not yet recruiting
Dec. 23, 2020
Safety and Efficacy of AQW051 in L-dopa Induced Dyskinesias in Patients With Parkinson's Disease
Trial
Phase 2
Completed
Dec. 23, 2020
Shoulder Disorders in Patients With Parkinson's Disease
Trial
N/A
Completed
Dec. 22, 2020
Evaluation of the Efficacy and Safety of AFQ056 in Parkinson's Patients With L-dopa Induced Dyskinesias
Trial
Phase 2
Completed
Dec. 22, 2020
Open-label, Long-term Safety Extension Study of AFQ056 in Parkinson's Patients With L-dopa Induced Dyskinesias
Trial
Phase 2
Completed
Dec. 22, 2020
Evaluation of the Efficacy and Safety of Modified Release AFQ056 in Parkinson's Patients With L-dopa Induced Dyskinesias
Trial
Phase 2
Completed
Dec. 22, 2020
Open Label, Safety, Tolerability and Efficacy of AFQ056 in Parkinson's Patients With L-dopa Induced Dyskinesias
Trial
Phase 2
Completed
Dec. 22, 2020
Vibration Impact on Parkinson's Tremor
Trial
N/A
Completed
Dec. 16, 2020
Evaluation of [18F]PI-2620 as a Potential Positron Emission Computed Tomography Radioligand for Imaging Tau Protein in the Brain
Trial
Early Phase 1
Completed
Dec. 13, 2020
Oxford Study of Quantification in Parkinsonism
Trial
N/A
Unknown
Dec. 10, 2020
Health Related Quality of Life in LCIG Patients and LCIG Eligible Patients Continuing Oral Therapy
Trial
N/A
Completed
Dec. 8, 2020
Binding of Foliglurax to Regions in the Brain in Healthy Participants and in Patients With Parkinson's Disease (PD)
Trial
Phase 1
Terminated
Dec. 8, 2020
PK Study in Patients With Parkinson's Disease With IZD174
Trial
Phase 1
Withdrawn
Dec. 3, 2020
Effect of Dual Task on Upper and Lower Extremity Skills in Parkinson's Disease
Trial
N/A
Completed
Dec. 2, 2020
Retinal Abnormalities as Biomarker of Disease Progression and Early Diagnosis of Parkinson Disease
Trial
N/A
Completed
Dec. 1, 2020
Safety and Efficacy of THN102 in Patients With Parkinson's Disease and Excessive Daytime Sleepiness
Trial
Phase 2
Completed
Nov. 30, 2020
MER Versus MRI Guidance DBS in Parkinson's Disease
Trial
N/A
Completed
Nov. 24, 2020
Efficacy, Safety and Tolerability of PF-06649751 in Parkinson's Disease Patients at Early Stage of the Disease
Trial
Phase 2
Terminated
Nov. 22, 2020
Efficacy, Safety and Tolerability of PF-06649751 in Parkinson's Disease Patients With Motor Fluctuations
Trial
Phase 2
Terminated
Nov. 22, 2020